Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Minimal Resistance Disease (MRD)

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance

Leukemia volume 15, pages 1066–1071 (2001)Cite this article

Abstract

Most prognostic factors in childhood acute lymphoblastic leukemia (ALL) are informative for groups of patients, whereas new approaches are needed to predict the efficacy of chemotherapy for the individual patient. The residual leukemia following 4 weeks of induction therapy with prednisolone, vincristine, doxorubicin and i.t. methotrexate and the in vitro resistance to prednisolone, vincristine, and doxorubicin were measured in 30 boys and 12 girls with B (n = 34) or T lineage (n = 8) ALL. The residual leukemia was quantified after 2 (MRD-D15, n = 29) and 4 weeks (MRD-PI, n = 42) of induction therapy with a precise and reproducible clone-specific PCR technique. The median MRD-D15 and MRD-PI were 0.50% (75% range 0.008–8.1%) and 0.014% (75% range 0.001–2.0%), respectively, and these levels correlated significantly (n = 29, rS = 0.75, P < 0.001). both the mrd-d15 and the mrd-pi were related to the age of the patient (mrd-d15: rS = 0.48, P = 0.009; MRD-PI: rS = 0.45, P = 0.003). Patients with T lineage ALL had higher MRD-PI than those with B lineage ALL (median MRD-PI: 0.5% vs 0.01%, P = 0.05). The median LC50 (concentration lethal to 50% of cells) for prednisolone was 2.3 μg/ml (75% range 0.05–668). Both MRD-D15 and MRD-PI correlated significantly with the in vitro resistance to prednisolone (MRD-D15: rS = 0.41, P = 0.03; MRD-PI: rS = 0.39, P = 0.01); but not to in vitro vincristine or doxorubicin resistance. The correlations between MRD and in vitro prednisolone resistance were even more pronounced when B cell precursor and T cell leukemia were analyzed separately (B cell precursor ALL: MRD-PI vs prednisolone LC50: n = 33, rS = 0.47, P = 0.006; T cell ALL: MRD-PI vs prednisolone resistance: n = 8, rS = 0.84, P = 0.009). After a median follow-up of 5.0 years (75% range 3.2–6.9) eight patients have relapsed. All of the 21 patients with a MRD-PI ⩽0.5% and a prednisolone LC50 ⩽10 μg/ml have remained in remission whereas the 7 year event-free survival for the remaining 20 patients was 0.45 ± 0.16 (P = 0.002) Prospective studies in childhood ALL are needed to clarify whether combined monitoring of in vitro drug resistance and residual leukemia early during chemotherapy could offer new ways to classify patients and stratify the intensity of therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122–3133

    CAS  PubMed  Google Scholar 

  2. Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, Hammond GD . Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group J Clin Oncol 1989 7: 1807–1815

    Article  CAS  PubMed  Google Scholar 

  3. Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman P, Miller DR, Reaman G, Sather H, Hammond GD . Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features Med Pediatr Oncol 1990 18: 273–279

    Article  CAS  PubMed  Google Scholar 

  4. Lilleyman JS, Gibson BE, Stevens RF, Will AM, Hann IM, Richards SM, Hill FG . Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia Br J Haematol 1997 97: 603–606

    Article  CAS  PubMed  Google Scholar 

  5. Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG, Uckun FM . Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review Cancer 1997 80: 1717–1726

    Article  CAS  PubMed  Google Scholar 

  6. Kaspers GJ, Pieters R, Van Zantwijk CH, van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ . Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro–vivo correlations and cross-resistance to other drugs Blood 1998 92: 259–266

    CAS  PubMed  Google Scholar 

  7. Pieters R, Klumper E, Kaspers GJ, Veerman AJ . Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia Crit Rev Oncol Hematol 1997 25: 11–26

    Article  CAS  PubMed  Google Scholar 

  8. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, van Wering ER, Van Der Does-Van Den Berg A . In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia Blood 1997 90: 2723–2729

    CAS  PubMed  Google Scholar 

  9. Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R . In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia Blood 1997 89: 2959–2965

    CAS  PubMed  Google Scholar 

  10. Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G . Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia J Clin Oncol 1992 10: 1879–1888

    Article  CAS  PubMed  Google Scholar 

  11. Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H . Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction Lancet 1994 343: 196–200

    Article  CAS  PubMed  Google Scholar 

  12. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d'Auriol L . Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T cell receptor genes Blood 1994 83: 1892–1902

    CAS  PubMed  Google Scholar 

  13. Cave H, van der Werff ten Bosch, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group N Engl J Med 1998 339: 591–598

    Article  CAS  PubMed  Google Scholar 

  14. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, De Bruijn MA, Cazzaniga G, Hettinger K, Van Der Does-Van Den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 1998 352: 1731–1738

    Article  CAS  PubMed  Google Scholar 

  15. Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia Lancet 1998 351: 550–554

    Article  CAS  PubMed  Google Scholar 

  16. Jonsson OG, Kitchens RL, Scott FC, Smith RG . Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes Blood 1990 76: 2072–2079

    CAS  PubMed  Google Scholar 

  17. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkkiperna A, Nygard R, Saarinen-Pihkala UM . Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation Leukemia 2000 14: 2267–2275

    Article  CAS  PubMed  Google Scholar 

  18. Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Engel CA, Svejgaard A, Wesenberg F, Schmiegelow K . Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia J Immunol Meth 2000 233: 107–118

    Article  CAS  Google Scholar 

  19. Kaspers GJ, Pieters R, Van Zantwijk CH, De Laat PA, de Waal FC, van Wering ER, Veerman AJ . In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood Br J Cancer 1991 64: 469–474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pieters R, Huismans DR, Leyva A, Veerman AJ . Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia Cancer Lett 1988 41: 323–332

    Article  CAS  PubMed  Google Scholar 

  21. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MW, Heyenbrok MW, Hahlen K, Veerman AJ . In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions Blood 1990 76: 2327–2336

    CAS  PubMed  Google Scholar 

  22. Kaspers GJ, Veerman AJ, Pieters R, Broekema GJ, Huismans DR, Kazemier KM, Loonen AH, Rottier MA, Van Zantwijk CH, Hahlen K . Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay Br J Cancer 1994 70: 1047–1052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pieters R, Huismans DR, Leyva A, Veerman AJ . Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia Br J Cancer 1989 59: 217–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Siegel S, Castellan NJ . Nonparametric Statistics for the Behavioral Sciences McGraw Hill: Singapore 1988

    Google Scholar 

  25. Cox DR . Regression models and life-tables (with discussion) J R Stat Soc (B) 1972 34: 187–220

    Google Scholar 

  26. Kaplan EJ, Meier P . Non-parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  27. Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother 1966 50: 163–170

    CAS  Google Scholar 

  28. SPSS statistical software for Windows release 10.0.5. SPSS Inc. 1999

  29. Lonsdale D, Gehan EA, Fernbach DJ, Sullivan MP, Lane DM, Ragab AH . Interrupted vs. continued maintenance therapy in childhood acute leukemia Cancer 1975 36: 341–352

    Article  CAS  PubMed  Google Scholar 

  30. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM . Treatment of acute lymphoblastic leukemia. 30 years’ experience at St Jude Children's Research Hospital N Engl J Med 1993 329: 1289–1295

    Article  CAS  PubMed  Google Scholar 

  31. Gustafsson G, Kreuger A, Clausen N, Garwicz S, Kristinsson J, Lie SO, Moe PJ, Perkkio M, Yssing M, Saarinen-Pihkala UM . Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) Acta Paediatr 1998 87: 1151–1161

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study has received financial support from The Danish Cancer Society (grant No. 94-100-28 and 96-100-07), The Emil and Inger Hertz Foundation, The Kornerup Foundation, The Medical Research Council, Denmark (grant No. 9401011), The Queen Louise's Children's Hospital Foundation.

Author information

Authors and Affiliations

  1. Department of Pediatrics, The National University Hospital, Rigshospitalet, Copenhagen, Denmark

    K Schmiegelow & N Knabe

  2. Department of Clinical Immunology, The National University Hospital, Rigshospitalet, Copenhagen, Denmark

    C Nyvold, J Seyfarth, LP Ryder, HO Madsen & A Svejgaard

  3. Sophia Children's University Hospital, Rotterdam, The Netherlands

    R Pieters

  4. University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    MMA Rottier & GJL Kaspers

Authors
  1. K Schmiegelow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Nyvold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Seyfarth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Pieters
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. MMA Rottier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Knabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. LP Ryder
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. HO Madsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Svejgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. GJL Kaspers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmiegelow, K., Nyvold, C., Seyfarth, J. et al. Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia 15, 1066–1071 (2001). https://doi.org/10.1038/sj.leu.2402144

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402144

Keywords

This article is cited by

Search

Advanced search

Quick links